Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 34 USDMF, 29 CEP/COS, 9 JDMF, 7 EU WC, 7 KDMF, 28 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

309 FDF Dossiers, 40 FDA Orange Book, 131 Europe, 21 Canada, 59 Australia, 28 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 10 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 21 Solubilizers, 17 Thickeners and Stabilizers, 17 Direct Compression, 11 Parenteral, 10 Coating Systems & Additives, 10 Co-Processed Excipients, 10 Topical, 9 Film Formers & Plasticizers, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 5 Controlled & Modified Release, 5 Rheology Modifiers, 3 Lubricants & Glidants, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 110 Finished Drug Prices, 14 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20762 / DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MOMETASONE FUROATE MONOHYDRATE(UNII: MTW0WEG809) (Mometasone - UNII:8HR4QJ6DW8)	Mometasone	50ug

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	Merck Sharp & Dohme Corp.	REMEDYREPACK INC.	Sandoz Inc.
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)
carboxymethylcellulose sodium, unspecified form(K679OBS311)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
glycerin(PDC6A3C0OX)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
polysorbate 80(6OZP39ZG8H)
SODIUM CITRATE(1Q73Q2JULR)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)

Drug Product Composition: Mometasone Furoate